Jirong Long
Has grant
Professor
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Breast cancer genetic study in African-ancestry populations
Open Date: 2016-07-01
Close Date: 2021-06-01
Grant: Close
Southern Community Cohort Study
Open Date: 2016-07-01
Close Date: 2021-06-01
Grant: Close
Oral Microbiome and Lung Cancer risk
Open Date: 2016-07-01
Close Date: 2020-06-01
Grant: Close
Vitamin D and colorectal cancer risk: An integrated molecular and genetic epidemiology study
Open Date: 2016-07-01
Close Date: 2018-06-01
Grant: Close
Analysis, Validation and Resource Creation for Genome Sequencing of Complex Diseases
Open Date: 2016-05-01
Close Date: 2020-04-01
Articles (7)
Supplementary Table 1 shows the associations of total and LDL cholesterols with colorectal cancer risk among non-users of cholesterol-lowering medications, stratified by sex, cancer subsite and age at diagnosis.
Year:
2025
Background: Despite a healthy lifestyle being linked to reduced colorectal cancer risk, prior studies using surveys to measure lifestyle factors failed to consider potential interindividual heterogeneity in metabolic responses. We aimed to characterize a metabolic signature as a measure of metabolic responses to a healthy lifestyle and evaluate its association with colorectal cancer risk. Methods: Among 211,135 UK Biobank participants, we derived a healthy lifestyle score from eight lifestyle components and applied elastic net regression to derive its metabolic signature from 249 biomarkers in plasma samples collected at baseline. Cox proportional hazards models were used to estimate HRs and 95% confidence intervals (CI) for the association of the signature with colorectal cancer risk. To infer potential causality of the signature, we conducted a genome-wide association study among 184,765 UK Biobank participants of European ancestry, followed by a two-sample Mendelian randomization analysis in 78,473 colorectal cancer cases and 107,143 controls of European ancestry. Results: The metabolic signature, which explained 32.6% of the total variance in the healthy lifestyle score, was associated with 12% lower colorectal cancer risk (HR = 0.88; 95% CI, 0.84–0.92 per SD increase; P trend P value Conclusions: A metabolic signature characterizing a healthy lifestyle was inversely associated with colorectal cancer risk. Certain biomarkers constituting the signature may be involved in the lifestyle pathway for colorectal cancer incidence. Impact: Our study further supported lifestyle modifications and identified potential targets for colorectal cancer prevention.
Year:
2025
Breast cancer includes several subtypes with distinct characteristic biological, pathologic, and clinical features. Elucidating subtype-specific genetic etiology could provide insights into the heterogeneity of breast cancer to facilitate the development of improved prevention and treatment approaches. In this study, we conducted pairwise case–case comparisons among five breast cancer subtypes by applying a case–case genome-wide association study (CC-GWAS) approach to summary statistics data of the Breast Cancer Association Consortium. The approach identified 13 statistically significant loci and eight suggestive loci, the majority of which were identified from comparisons between triple-negative breast cancer (TNBC) and luminal A breast cancer. Associations of lead variants in 12 loci remained statistically significant after accounting for previously reported breast cancer susceptibility variants, among which, two were genome-wide significant. Fine mapping implicated putative functional/causal variants and risk genes at several loci, e.g., 3q26.31/ TNFSF10 , 8q22.3/ NACAP1 / GRHL2 , and 8q23.3/ LINC00536 / TRPS1 , for TNBC as compared with luminal cancer. Functional investigation further identified rs16867605 at 8q22.3 as a SNP that modulates the enhancer activity of GRHL2 . Subtype-informative polygenic risk scores (PRS) were derived, and patients with a high subtype-informative PRS had an up to two-fold increased risk of being diagnosed with TNBC instead of luminal cancers. The CC-GWAS PRS remained statistically significant after adjusting for TNBC PRS derived from traditional case–control GWAS in The Cancer Genome Atlas and the African Ancestry Breast Cancer Genetic Consortium. The CC-GWAS PRS was also associated with overall survival and disease-specific survival among patients with breast cancer. Overall, these findings have advanced our understanding of the genetic etiology of breast cancer subtypes, particularly for TNBC. Significance: The discovery of subtype-informative genetic risk variants for breast cancer advances our understanding of the etiologic heterogeneity of breast cancer, which could accelerate the identification of targets and personalized strategies for prevention and treatment.
Year:
2024
Alternative polyadenylation (APA) modulates mRNA processing in the 3′-untranslated regions (3′ UTR), affecting mRNA stability and translation efficiency. Research into genetically regulated APA has the potential to provide insights into cancer risk. In this study, we conducted large APA-wide association studies to investigate associations between APA levels and cancer risk. Genetic models were built to predict APA levels in multiple tissues using genotype and RNA sequencing data from 1,337 samples from the Genotype-Tissue Expression project. Associations of genetically predicted APA levels with cancer risk were assessed by applying the prediction models to data from large genome-wide association studies of six common cancers among European ancestry populations: breast, ovarian, prostate, colorectal, lung, and pancreatic cancers. A total of 58 risk genes (corresponding to 76 APA sites) were associated with at least one type of cancer, including 25 genes previously not linked to cancer susceptibility. Of the identified risk APAs, 97.4% and 26.3% were supported by 3′-UTR APA quantitative trait loci and colocalization analyses, respectively. Luciferase reporter assays for four selected putative regulatory 3′-UTR variants demonstrated that the risk alleles of 3′-UTR variants, rs324015 ( STAT6 ), rs2280503 ( DIP2B ), rs1128450 ( FBXO38 ), and rs145220637 ( LDHA ), significantly increased the posttranscriptional activities of their target genes compared with reference alleles. Furthermore, knockdown of the target genes confirmed their ability to promote proliferation and migration. Overall, this study provides insights into the role of APA in the genetic susceptibility to common cancers. Significance: Systematic evaluation of associations of alternative polyadenylation with cancer risk reveals 58 putative susceptibility genes, highlighting the contribution of genetically regulated alternative polyadenylation of 3′UTRs to genetic susceptibility to cancer.
Year:
2024
Alternative polyadenylation (APA) modulates mRNA processing in the 3′-untranslated regions (3′ UTR), affecting mRNA stability and translation efficiency. Research into genetically regulated APA has the potential to provide insights into cancer risk. In this study, we conducted large APA-wide association studies to investigate associations between APA levels and cancer risk. Genetic models were built to predict APA levels in multiple tissues using genotype and RNA sequencing data from 1,337 samples from the Genotype-Tissue Expression project. Associations of genetically predicted APA levels with cancer risk were assessed by applying the prediction models to data from large genome-wide association studies of six common cancers among European ancestry populations: breast, ovarian, prostate, colorectal, lung, and pancreatic cancers. A total of 58 risk genes (corresponding to 76 APA sites) were associated with at least one type of cancer, including 25 genes previously not linked to cancer susceptibility. Of the identified risk APAs, 97.4% and 26.3% were supported by 3′-UTR APA quantitative trait loci and colocalization analyses, respectively. Luciferase reporter assays for four selected putative regulatory 3′-UTR variants demonstrated that the risk alleles of 3′-UTR variants, rs324015 ( STAT6 ), rs2280503 ( DIP2B ), rs1128450 ( FBXO38 ), and rs145220637 ( LDHA ), significantly increased the posttranscriptional activities of their target genes compared with reference alleles. Furthermore, knockdown of the target genes confirmed their ability to promote proliferation and migration. Overall, this study provides insights into the role of APA in the genetic susceptibility to common cancers. Significance: Systematic evaluation of associations of alternative polyadenylation with cancer risk reveals 58 putative susceptibility genes, highlighting the contribution of genetically regulated alternative polyadenylation of 3′UTRs to genetic susceptibility to cancer.
Year:
2024
Breast cancer includes several subtypes with distinct characteristic biological, pathologic, and clinical features. Elucidating subtype-specific genetic etiology could provide insights into the heterogeneity of breast cancer to facilitate the development of improved prevention and treatment approaches. In this study, we conducted pairwise case–case comparisons among five breast cancer subtypes by applying a case–case genome-wide association study (CC-GWAS) approach to summary statistics data of the Breast Cancer Association Consortium. The approach identified 13 statistically significant loci and eight suggestive loci, the majority of which were identified from comparisons between triple-negative breast cancer (TNBC) and luminal A breast cancer. Associations of lead variants in 12 loci remained statistically significant after accounting for previously reported breast cancer susceptibility variants, among which, two were genome-wide significant. Fine mapping implicated putative functional/causal variants and risk genes at several loci, e.g., 3q26.31/ TNFSF10 , 8q22.3/ NACAP1 / GRHL2 , and 8q23.3/ LINC00536 / TRPS1 , for TNBC as compared with luminal cancer. Functional investigation further identified rs16867605 at 8q22.3 as a SNP that modulates the enhancer activity of GRHL2 . Subtype-informative polygenic risk scores (PRS) were derived, and patients with a high subtype-informative PRS had an up to two-fold increased risk of being diagnosed with TNBC instead of luminal cancers. The CC-GWAS PRS remained statistically significant after adjusting for TNBC PRS derived from traditional case–control GWAS in The Cancer Genome Atlas and the African Ancestry Breast Cancer Genetic Consortium. The CC-GWAS PRS was also associated with overall survival and disease-specific survival among patients with breast cancer. Overall, these findings have advanced our understanding of the genetic etiology of breast cancer subtypes, particularly for TNBC. Significance: The discovery of subtype-informative genetic risk variants for breast cancer advances our understanding of the etiologic heterogeneity of breast cancer, which could accelerate the identification of targets and personalized strategies for prevention and treatment.
Year:
2024
Breast cancer includes several subtypes with distinct characteristic biological, pathologic, and clinical features. Elucidating subtype-specific genetic etiology could provide insights into the heterogeneity of breast cancer to facilitate the development of improved prevention and treatment approaches. In this study, we conducted pairwise case–case comparisons among five breast cancer subtypes by applying a case–case genome-wide association study (CC-GWAS) approach to summary statistics data of the Breast Cancer Association Consortium. The approach identified 13 statistically significant loci and eight suggestive loci, the majority of which were identified from comparisons between triple-negative breast cancer (TNBC) and luminal A breast cancer. Associations of lead variants in 12 loci remained statistically significant after accounting for previously reported breast cancer susceptibility variants, among which, two were genome-wide significant. Fine mapping implicated putative functional/causal variants and risk genes at several loci, e.g., 3q26.31/ TNFSF10 , 8q22.3/ NACAP1 / GRHL2 , and 8q23.3/ LINC00536 / TRPS1 , for TNBC as compared with luminal cancer. Functional investigation further identified rs16867605 at 8q22.3 as a SNP that modulates the enhancer activity of GRHL2 . Subtype-informative polygenic risk scores (PRS) were derived, and patients with a high subtype-informative PRS had an up to two-fold increased risk of being diagnosed with TNBC instead of luminal cancers. The CC-GWAS PRS remained statistically significant after adjusting for TNBC PRS derived from traditional case–control GWAS in The Cancer Genome Atlas and the African Ancestry Breast Cancer Genetic Consortium. The CC-GWAS PRS was also associated with overall survival and disease-specific survival among patients with breast cancer. Overall, these findings have advanced our understanding of the genetic etiology of breast cancer subtypes, particularly for TNBC. Significance: The discovery of subtype-informative genetic risk variants for breast cancer advances our understanding of the etiologic heterogeneity of breast cancer, which could accelerate the identification of targets and personalized strategies for prevention and treatment.
Year:
2024
Collaborators (36)
Montserrat Garcia-Closas
Professor of Epidemiology
Institute of Cancer Research
Christopher A. Haiman
University of Southern California
Andriy Derkach
Associate Attending Biostatistician
Memorial Sloan Kettering Cancer Center
Christine Ambrosone
Roswell Park Comprehensive Cancer Center
Jennifer Hu
Professor
University of Miami
Danxia Yu
Vanderbilt University Medical Center
Katherine Nathanson
Professor
University of Pennsylvania
Xiao‐Ou Shu
Vanderbilt University Medical Center
Shiv Prakash Verma
Senior Research Scientist
Memorial Sloan Kettering Cancer Center
Qingrun Zhang
Assistant Professor
University of Calgary
Ulrike Peters
Fred Hutchinson Cancer Research Center
Stefan Ambs
Senior Investigator (tenured) and Head of the Molecular Epidemiology Section
National Cancer Institute
Dale Sandler
Branch Chief
National Institute of Environmental Health Sciences
Julie R Palmer
Boston University School of Medicine
Wei Zheng
-
Weiqiang Lin
Professor
Zhejiang University
Qiuyin Cai
Professor
Vanderbilt University Medical Center
Mohsen Ghanbari
Associate professor
Erasmus MC
Ran Tao
Associate Professor
Vanderbilt University Medical Center
Melissa A. Troester
Professor
University of North Carolina at Chapel Hill
GUOCHONG JIA
Vanderbilt University
Andrew Olshan
University of North Carolina at Chapel Hill
Esther John
Professor
Stanford University School of Medicine
Charles F. Lynch
-
Zhishan Chen
staff Scientist
Vanderbilt University
Dezheng Huo
University of Chicago
Gordon Watt
Junior Group Leader
The Netherlands Cancer Institute
Xingyi Guo
Associate Professor
Vanderbilt University Medical Center
Graham Casey
University of Virginia
Yaohua Yang
Assistant Professor
University of Virginia
Jian Gu
The University of Texas MD Anderson Cancer Center
Olufunmilayo I. Olopade
Professor
University of Chicago
Christopher Li
Fred Hutchinson Cancer Research Center
Stephen Gruber
Professor
City Of Hope National Medical Center
Graham Giles
Head of Research
-
Pavel Vodička
senior researcher
Charles University
Make your next move.
Prepare your application
Review drafts before you send them.